Key facts
- Ivory (Healthcare Technology Systems)’s last known valuation is $4.9M (Apr 2025).
- It has raised $2.5M; the latest was Later Stage VC ($1.0M) in Apr 2026.
- Notable investors include Draper Associates, Capital A Partners (Netherlands), Rajeev Singh, 1Crowd, AL Trust (India) — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Ivory (Healthcare Technology Systems)
- ·The full record, as it builds
Funding rounds
No funding rounds for Ivory (Healthcare Technology Systems) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ivory (Healthcare Technology Systems)
Developer of a brain health screening system designed to understand brain health. The company detects neurodegenerative risks early and offers personalized brain health services through neuroscience-backed assessments and interactive games, enabling the elderly to help fight dementia.
- Sector
- Healthcare
- HQ
- Delhi, India
- Founded
- 2021
- Employees
- 5
- Website
- liveivory.com/
- Ownership
- Privately Held (backing)
Ivory (Healthcare Technology Systems) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ivory (Healthcare Technology Systems) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ivory (Healthcare Technology Systems) in its N-PORT filings yet. We sweep new filings monthly.